Cite
HARVARD Citation
Han, E. et al. (2016). Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes. Medicine. 95 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Han, E. et al. (2016). Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes. Medicine. 95 (6), p. . [Online].